RepliCel Life Sciences Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2014 - 2018
Period Ending	Feb '25 Feb 28, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2014 - 2018
Market Capitalization	0	4	3	9	7	9	Upgrade
Market Cap Growth	-49.67%	29.89%	-66.36%	21.67%	-16.80%	-9.82%	Upgrade
Enterprise Value	2	5	4	9	8	9	Upgrade
Last Close Price	0.01	0.07	0.09	0.23	0.23	0.26	Upgrade
PS Ratio	-	10.92	8.41	24.99	20.54	24.69	Upgrade
PB Ratio	-	-0.85	-0.50	-1.29	-1.44	-1.97	Upgrade
EV/Sales Ratio	4.23	13.07	10.18	25.83	21.91	25.35	Upgrade
Debt / Equity Ratio	-0.25	-0.19	-0.12	-0.09	-0.12	-0.10	Upgrade
Asset Turnover	1.47	0.65	0.51	0.70	0.76	0.18	Upgrade
Quick Ratio	0.02	0.06	0.25	0.18	0.05	0.07	Upgrade
Current Ratio	0.02	0.09	0.31	0.23	0.08	0.15	Upgrade
Return on Assets (ROA)	-148.73%	-159.56%	-125.49%	-284.04%	-182.20%	-95.54%	Upgrade
Earnings Yield	652.32%	-8.07%	-24.99%	-46.08%	-21.75%	-34.40%	Upgrade
FCF Yield	-	-36.61%	-47.39%	-28.44%	-10.53%	-31.85%	Upgrade
Buyback Yield / Dilution	-52.12%	-56.86%	-16.26%	-20.50%	-11.84%	-10.31%	Upgrade
Total Shareholder Return	-52.12%	-56.86%	-16.26%	-20.50%	-11.84%	-10.31%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.